Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.32 USD | +0.44% | +3.85% | -32.82% |
Apr. 04 | North American Morning Briefing : Focus Turns to -2- | DJ |
Apr. 03 | Citigroup Upgrades Sotera Health to Buy From Neutral, Cuts Price Target to $16 From $18 | MT |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- The company's profit outlook over the next few years is a strong asset.
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Analyst opinion has improved significantly over the past four months.
Weaknesses
- One of the major weak points of the company is its financial situation.
- With an expected P/E ratio at 33.11 and 21.87 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- With an enterprise value anticipated at 4.67 times the sales for the current fiscal year, the company turns out to be overvalued.
- The company appears highly valued given the size of its balance sheet.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-32.82% | 3.2B | C- | ||
-14.73% | 84.87B | B- | ||
+16.05% | 83.08B | C+ | ||
+10.92% | 29.4B | C+ | ||
-12.73% | 16.72B | B | ||
-3.49% | 16.4B | A- | ||
-1.78% | 15.04B | A- | ||
+0.05% | 11.88B | A- | ||
-31.75% | 11.86B | - | - | |
-4.95% | 11.88B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- SHC Stock
- Ratings Sotera Health Company